PPT-Josep Tabernero, MD PhD Medical Oncology Department Vall
Author : test | Published Date : 2019-11-06
Josep Tabernero MD PhD Medical Oncology Department Vall dHebron University Hospital amp Vall dHebron Institute of Oncology Barcelona Spain Molecular subtyping in
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Josep Tabernero, MD PhD Medical Oncolo..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Josep Tabernero, MD PhD Medical Oncology Department Vall: Transcript
Josep Tabernero MD PhD Medical Oncology Department Vall dHebron University Hospital amp Vall dHebron Institute of Oncology Barcelona Spain Molecular subtyping in colorectal cancer implications for therapeutic decisions. Gary E. Foresman, MD. February 2012. “In 2010, about 600,000 Americans, and more than 7 million humans around the world, will die of cancer. . In the United States, 1 in 3 women and 1 in 2 men will develop cancer during their lifetime. . Gary E. Foresman, MD. February 2012. “In 2010, about 600,000 Americans, and more than 7 million humans around the world, will die of cancer. . In the United States, 1 in 3 women and 1 in 2 men will develop cancer during their lifetime. . originalresearchAn8-YearLongitudinalStudyofOverreachingin114EliteFemaleChineseWrestlersYeTian,PhD*;ZihongHe,PhD*;JiexiuZhao,PhD*;DalangTao,MA;KuiyuanXu,MA;AdrianMidgley,PhD;LarsMcNaughton,PhD Journalo ASCO June 2014. Susan Dent. Medical Oncologist. The Ottawa Hospital Cancer Center. Ottawa, Canada. The problem . Cancer Survivors (Million) 2012 - 2018. Brigham, MGH. MSK. U Penn. Medstar. Washington. theacp.org.uk @ACPUK. Medical Oncology . - responsible for overseeing the treatment of patients with cancer. Dynamic, Challenging and Rewarding. @. acpuk. theacp.org.uk. Increasing incidence . Background on Tonga. Tonga’s population: 103,252. 73% live on main island.. Proportion <. 15yo- 38,457 (37.2%) . Vaiola. is the one main hospital for the kingdom. We have ~120 admissions per month to our paediatric ward. The Need for Measurement. Payers (Medicare and private insurers) are demanding quality, cost control, accountability, and predictability. Measuring . quality and value in cancer care now enabled by IT . Matthew Marston, . Pharm.D. ., BCPS. Miller Drug, LLC. Oral Oncolytics. Objectives. Identify . opportunities and challenges associated with the recent growth of the oral oncolytic market. .. Describe . Maximizing Nutrition in Oncology Patients Laura Kerns, MPH, RD, CSO, LDN Board Certified Specialist in Oncology Nutrition Malnutrition and cachexia Malabsorption XRT and feeding tubes Opioid induced constipation Department of Obstetrics and Gynecology ________________________________________________________________________________________________________Division of Gynecologic OncologyEducationProgram for Fel Ofce HoursMonday to Friday, 8 a.m. to 5 p.m. Tower Health PartnersHEMATOLOGY ONCOLOGY - ower Health Medical Group ® Routine referrals may be placed in EPIC. Non-EPIC providers may refer patients Debbie Bickes, MN, RN, OCN. ®. Supervisor, Oncology Patient Navigation. Northside Hospital Cancer Institute. Objectives. Explain oncology patient navigation. Provide a brief description of the history and evolution of oncology patient navigation. service NBT. Charly Moran – Clinical Specialist Physiotherapist in Neuro-oncology at NBT. Eleanor Guiney - Clinical Specialist Speech and Language Therapists . in Neuro-oncology. at NBT. RESOURCE :. Dr Ollie Minton . National Picture. 29% . NHS spending is on patients in the . last year of their life. 1:3 . of the adult inpatient population is in the last year of their life. 1:10. is in their last admission.
Download Document
Here is the link to download the presentation.
"Josep Tabernero, MD PhD Medical Oncology Department Vall"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents